Forgery and misrepresentation in bioart market

Introduction

Bioart refers to an artistic practice that uses biological materials, living organisms, genetic technologies, tissue cultures and biotechnology-based processes to create artistic works. It combines science, technology and creative expression. Bioart may include genetically modified organisms, laboratory-grown tissues, biological installations and artworks incorporating synthetic biological materials.

The bioart market involves the creation, exhibition, purchase, sale and commercial licensing of such artworks. As this field develops, legal concerns arise regarding forgery, false scientific claims, unauthorised use of biological materials, intellectual property violations and misrepresentation of an artwork's origin or authenticity.

Forgery refers to deliberately creating or altering an artwork or its documentation to deceive buyers about its identity, authorship or origin. Misrepresentation occurs when sellers provide false or misleading information about an artwork's biological composition, scientific process, authenticity or commercial value.

Legal framework in India

1. Indian Contract Act, 1872

Sections 17 and 18 address fraud and misrepresentation respectively. If a buyer purchases a bioart product based on fraudulent statements or misleading information, the contract may be voidable under Section 19, subject to statutory conditions.

For example, a seller who falsely claims that an artwork contains genuine laboratory-grown human tissue may face contractual consequences if the claim induces the purchase.

2. Bharatiya Nyaya Sanhita, 2023

The BNS contains provisions addressing offences involving forgery, cheating and fraudulent conduct. Depending on the facts, deliberately falsifying certificates, ownership records or scientific documentation may attract criminal liability.

3. Copyright Act, 1957

Copyright protects original artistic works, subject to statutory requirements. Unauthorised reproduction, distribution or commercial exploitation of protected artwork may constitute copyright infringement.

4. Trade Marks Act, 1999

The Act protects registered trademarks and provides remedies against infringement and passing off. Misuse of an artist's name, studio identity or certification mark may create legal liability.

5. Consumer Protection Act, 2019

The Act protects consumers against misleading advertisements, unfair trade practices and false representations concerning goods and services.

Major forms of forgery and misrepresentation

1. False biological authenticity

A seller may falsely claim that an artwork contains genuine biological material, genetically modified organisms or laboratory-grown tissue when it does not.

Such conduct may mislead purchasers concerning the artwork's scientific composition and market value.

2. False authorship

An artwork may be presented as the original creation of a recognised bioartist even though it was created by another person without authorisation.

This may raise copyright, fraud and passing-off issues.

3. Manipulation of scientific certificates

Bioart transactions may involve certificates describing biological materials, laboratory processes, genetic characteristics or provenance. Deliberately falsifying such records may create civil and criminal liability.

4. Misrepresentation of genetic characteristics

Artists or sellers may exaggerate the genetic properties of an artwork or make unsupported claims about the organisms used in its creation.

Such statements may amount to misrepresentation where they materially influence a purchaser's decision.

5. False provenance and ownership

Provenance refers to the documented history of an artwork's creation, ownership and transfer. Fabricated ownership records or exhibition histories may mislead buyers and undermine the authenticity of the art market.

Legal responsibilities of bioart sellers and institutions

Artists, galleries, laboratories and commercial sellers should maintain transparent records concerning the origin and characteristics of biological artworks.

Important safeguards include:

Maintaining authentic ownership and provenance documents.

Providing accurate descriptions of biological materials.

Disclosing relevant scientific limitations.

Obtaining permission for the use of third-party intellectual property.

Maintaining genuine laboratory and research certificates.

Avoiding misleading advertising and commercial claims.

Ensuring lawful acquisition and use of biological materials.

Where human biological materials are involved, additional requirements concerning consent, privacy, ethics and applicable biomedical regulations may arise.

Important case laws

There are no widely recognised Indian judgments specifically dealing with forgery in the bioart market. However, established judicial decisions provide relevant principles.

1. S.P. Chengalvaraya Naidu v. Jagannath (1994)

The Supreme Court held that fraud undermines the administration of justice and that a judgment obtained through fraud may be treated as a nullity.

This principle is relevant where parties submit fabricated ownership documents or false scientific certificates to establish rights over a bioart object.

2. A.V. Papayya Sastry v. Government of Andhra Pradesh (2007)

The Supreme Court reaffirmed that fraud vitiates judicial and legal proceedings. It emphasised that fraudulent conduct cannot be protected by the finality of an earlier decision.

The principle is relevant to disputes involving forged provenance records and fraudulent claims of ownership.

3. Lalman Shukla v. Gauri Dutt (1913)

The Allahabad High Court examined the principles of acceptance and knowledge in contractual relationships.

Although the case did not concern artistic fraud, it provides useful background for understanding the legal requirements governing contractual obligations and representations.

4. Cadila Healthcare Ltd. v. Cadila Pharmaceuticals Ltd. (2001)

The Supreme Court discussed the principles governing deceptive similarity and passing off in commercial transactions.

The judgment is relevant where a seller uses another artist's identity, brand or studio reputation to mislead purchasers about the origin of a bioart product.

International legal framework

International intellectual property and commercial law principles also influence the bioart market.

Berne Convention, 1886: Provides international protection for literary and artistic works.

TRIPS Agreement, 1994: Establishes minimum international standards for intellectual property protection.

UNESCO Universal Declaration on Bioethics and Human Rights, 2005: Provides ethical principles concerning human dignity, consent and scientific research.

Convention on Biological Diversity, 1992: Provides a framework for biodiversity conservation and sustainable use of biological resources.

These instruments support responsible artistic innovation and protection of intellectual property and biological resources.

Challenges in regulating the bioart market

The bioart market faces several legal and practical challenges:

Difficulty verifying the biological authenticity of artworks.

Lack of standardised certification procedures.

Complex ownership rights involving artists and research institutions.

Potential misuse of human biological materials.

Difficulty distinguishing scientific claims from artistic representations.

Cross-border disputes involving ownership and intellectual property.

Limited specialised legal standards for biological artworks.

Conclusion

Forgery and misrepresentation in the bioart market create serious challenges for artistic authenticity, consumer protection and scientific integrity. Indian laws, including the Indian Contract Act, 1872, Bharatiya Nyaya Sanhita, 2023, Copyright Act, 1957 and Consumer Protection Act, 2019, provide important legal mechanisms for addressing fraudulent practices. Judicial decisions such as S.P. Chengalvaraya Naidu v. Jagannath and A.V. Papayya Sastry v. Government of Andhra Pradesh establish that fraud cannot be legally protected. Transparent provenance records, accurate scientific disclosures and stronger certification practices are essential for maintaining trust and accountability in the developing bioart market.